Cellectar Biosciences, Inc. Derivative Liability, Current
Cellectar Biosciences, Inc. (CLRB) had Derivative Liability, Current of $17.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Derivative Liability, Current $17.00K.
- 2026-03-31: Derivative Liability, Current $149.00K.
- 2025-12-31: Derivative Liability, Current $226.00K.
- 2025-09-30: Derivative Liability, Current $801.65K.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $17.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $149.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $226.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $801.65K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.10M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.06M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.72M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $11.93M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $8.63M 10-Q · filed 2024-10-29 | |
| 2024-03-31 | $21.08M 10-Q/A · filed 2024-10-29 | $8.80M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $16.12M 10-K · filed 2025-03-13 | $3.70M 10-K · filed 2024-03-27 |
| 2023-09-30 | $21.97M 10-K/A · filed 2024-10-29 | $8.60M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.54M 10-K/A · filed 2024-10-29 | |
| 2023-03-31 | $4.58M 10-K/A · filed 2024-10-29 | |
| 2022-12-31 | $5.97M 10-K/A · filed 2024-10-29 | |
| 2022-09-30 | $600.00K 10-K/A · filed 2024-10-29 | |
| 2022-06-30 | $900.00K 10-K/A · filed 2024-10-29 | |
| 2022-03-31 | $2.70M 10-K/A · filed 2024-10-29 | |
| 2019-12-31 | $0.00 10-K · filed 2020-03-09 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $46.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $47.00K 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $43.00K 10-K · filed 2020-03-09 | |
| 2018-09-30 | $86.00K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $152.00K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $132.00K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $105.05K 10-K · filed 2019-02-26 | |
| 2017-09-30 | $110.50K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $119.60K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $209.60K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $127.13K 10-K · filed 2018-03-21 | |
| 2016-09-30 | $187.65K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $365.56K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $1.96M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $4.78M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $4.65M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $4.88M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $4.89M 10-Q · filed 2015-05-20 | |
| 2014-12-31 | $5.18M 10-K/A · filed 2016-10-20 | $1.13M 10-K · filed 2015-03-24 |
| 2014-09-30 | $4.09M 10-Q · filed 2015-05-20 | $820.12K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $2.84M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $3.41M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $3.36M 10-Q · filed 2015-05-20 | |
| 2013-09-30 | $3.47M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $5.07M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $5.73M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $13.30K 10-K · filed 2014-03-19 | |
| 2012-09-30 | $21.63K 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $25.53K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $32.40K 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $23.30K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $77.97K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $81.54K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |